Menstruation recovery after chemotherapy and luteinizing hormone-releasing hormone agonist plus tamoxifen therapy for premenopausal patients with breast cancer

被引：0
|
作者：
Kenichi Sakurai
Sadanori Matsuo
Katsuhisa Enomoto
Sadao Amano
Motomi Shiono
机构：
[1] Nihon University School of Medicine,Division of Breast and Endocrine Surgery, Department of Surgery
来源：
Surgery Today | 2011年 / 41卷
关键词：
Luteinizing hormone-releasing hormone agonist; Adjuvant chemotherapy; Menstruation recovery; Premenopausal patients; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：48 / 53
页数：5
相关论文
共 50 条
  • [21] Luteinizing hormone-releasing hormone antagonists in prostate cancer
    Stricker, HJ
    UROLOGY, 2001, 58 (2A) : 24 - 27
  • [22] Agonists of luteinizing hormone-releasing hormone in prostate cancer
    Rick, Ferenc G.
    Block, Norman L.
    Schally, Andrew V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (16) : 2237 - 2247
  • [23] Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature
    Yanovski, JA
    Rose, SR
    Municchi, G
    Pescovitz, OH
    Hill, SC
    Cassorla, FG
    Cutler, GB
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10): : 908 - 917
  • [24] Future possibilities in the prevention of breast cancer - Luteinizing hormone-releasing hormone agonists
    Spicer, DV
    Pike, MC
    BREAST CANCER RESEARCH, 2000, 2 (04): : 264 - 267
  • [25] Is luteinizing hormone-releasing hormone agonist justified in short adolescents? Reply
    Lee, MM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02): : 193 - 193
  • [26] Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
    Lee, MM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10): : 942 - 945
  • [27] THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) AGONIST IN PREMENOPAUSAL ADVANCED BREAST-CANCER
    WILLIAMS, MR
    NICHOLSON, RI
    BLAMEY, RW
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 83 - 83
  • [28] Exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: Implications in the management of prostate cancer
    Chang, SS
    UROLOGY, 2003, 62 (6A) : 29 - 35
  • [29] Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer - Comment
    Klotz, LH
    UROLOGY, 1999, 53 (05) : 902 - 903
  • [30] THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) AGONIST IN PREMENOPAUSAL ADVANCED BREAST-CANCER
    WILLIAMS, MR
    WALKER, K
    NICHOLSON, RI
    TURKES, A
    BLAMEY, RW
    GRIFFITHS, K
    ANTICANCER RESEARCH, 1986, 6 (03) : 380 - 380
12345